Celebrating Our Successes of 2024
As 2024 draws to a close, we’re reflecting on an incredible year for our team. Since formally moving to QMUL at the end of 2023… Read More »Celebrating Our Successes of 2024
As 2024 draws to a close, we’re reflecting on an incredible year for our team. Since formally moving to QMUL at the end of 2023… Read More »Celebrating Our Successes of 2024
Elspeth Davies is a fourth year PhD student at the University of Cambridge. Funded by Cancer Research UK, her work uses anthropological methods to explore… Read More »On medical anthropology, understanding ‘risk’ and barriers to achieving interdisciplinarity in the world of cancer prevention: an interview with Elspeth Davies
This post was written by Chris Deeley. Chris is the Trial Coordinator for the BEST4 Screening trial, managed by the Cancer Prevention Trials Unit (CPTU)… Read More »The BEST4 Oesophageal Cancer Trial: marking the beginning of patient recruitment
Rebecca Fitzgerald OBE MACantab. MD FMedSci EMBO is Professor of Cancer Prevention at the University of Cambridge. She is Director of the newly established Early… Read More »5 minutes with: Professor Rebecca Fitzgerald
As another year draws to a close, what better way to recharge over the festive break than to dive into our 2022 paper round-up. Sticking… Read More »Cancer Prevention Group’s 2022 Christmas Reading List
This post is from the BEST3 event website, available here. Stay tuned over the coming weeks for more posts about the results from the BEST3 trial!… Read More »BEST3 – The Participant Perspective
This post is from the BEST3 event website, available here. Stay tuned over the coming weeks for more posts about the results from the BEST3 trial!… Read More »GP views on implementing the Cytosponge in Primary Care
This post is from the BEST3 event website, available here. Stay tuned over the coming weeks for more posts about the results from the BEST3 trial!… Read More »Pathology and Artificial Intelligence in BEST3
This post is from the BEST3 event website, available here. Stay tuned over the coming weeks for more posts about the results from the BEST3… Read More »Headline findings of the BEST3 Trial
In this post, we interview Rebecca Fitzgerald, chief investigator for the BEST3 trial. Her work at the MRC Cancer Unit focuses on the early detection… Read More »Best of BEST3: An interview with Rebecca Fitzgerald, Chief Investigator